BE904831A - Composition d'activateur tissulaire du plasminogene. - Google Patents

Composition d'activateur tissulaire du plasminogene.

Info

Publication number
BE904831A
BE904831A BE0/216712A BE216712A BE904831A BE 904831 A BE904831 A BE 904831A BE 0/216712 A BE0/216712 A BE 0/216712A BE 216712 A BE216712 A BE 216712A BE 904831 A BE904831 A BE 904831A
Authority
BE
Belgium
Prior art keywords
amino acid
activator composition
tissue activator
plasminogen tissue
acid sequence
Prior art date
Application number
BE0/216712A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521704A external-priority patent/GB8521704D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BE904831A publication Critical patent/BE904831A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Solution aqueuse parentérale d'un pH de 2 à 5 contenant du t-PA mono- ou bicaténaire qui a la séquence des aminoacides à laFig. 1 ou a la meme séquence des aminoacides, mais dont l'aminoacide à la position 245 à partir de l'extrémité N-terminale de la sérine est la valine au lieu de la méthionine, l'une ou l'autre séquence étant éventuellement exempte de l'un quelconque des trois premiers aminoacides ou comprenant éventuellement une préséquence de Gly-Ala-Arg supplémentaire N-terminale du polypeptide.
BE0/216712A 1985-05-28 1986-05-27 Composition d'activateur tissulaire du plasminogene. BE904831A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521704A GB8521704D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (1)

Publication Number Publication Date
BE904831A true BE904831A (fr) 1986-11-27

Family

ID=26289289

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216712A BE904831A (fr) 1985-05-28 1986-05-27 Composition d'activateur tissulaire du plasminogene.

Country Status (22)

Country Link
US (1) US5112609A (fr)
AT (1) AT391812B (fr)
AU (1) AU569429B2 (fr)
BE (1) BE904831A (fr)
CA (1) CA1297008C (fr)
CH (1) CH664495A5 (fr)
DE (1) DE3617753A1 (fr)
DK (1) DK163174C (fr)
ES (1) ES8706443A1 (fr)
FI (1) FI85334C (fr)
FR (1) FR2593393B1 (fr)
GB (1) GB2176703B (fr)
GR (1) GR861365B (fr)
HU (1) HU200695B (fr)
IL (1) IL78937A (fr)
IT (1) IT1191925B (fr)
LU (1) LU86445A1 (fr)
NL (1) NL8601354A (fr)
NO (1) NO171344C (fr)
NZ (1) NZ216306A (fr)
PT (1) PT82647B (fr)
SE (1) SE462893B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200615B (en) * 1982-05-05 1990-07-28 Genentech Inc Methods of preparing tissue plasiminogen activator derivative composition
FI831484A7 (fi) * 1982-05-05 1983-11-06 Genentech Inc Ihmiskudoksen plasminogeenien aktivaattori.
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
EP0214281B1 (fr) * 1985-03-06 1992-09-09 Survival Technology, Inc. Agents favorisant l'absorption de proteines
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
DE3715662A1 (de) * 1986-05-12 1987-11-19 Wellcome Found Neue pharmazeutische anwendung
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1990001334A1 (fr) * 1988-08-05 1990-02-22 Codon Formules d'activateur du plasminogene a base d'aspartate
GB8819607D0 (en) * 1988-08-17 1988-09-21 Wellcome Found Novel combination
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
GB9000629D0 (en) * 1990-01-11 1990-03-14 Porton Prod Ltd Tissue plasminogen activator
ATE155816T1 (de) * 1992-06-03 1997-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
CN1553811A (zh) * 2001-09-07 2004-12-08 ӡ�����Ƽ��ɷ����޹�˾ 人组织尿激酶类型纤溶酶原激活物制剂
WO2009149199A2 (fr) * 2008-06-04 2009-12-10 Talecris Biotherapeutics, Inc. Composition, méthode et nécessaire pour la préparation de plasmine
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (fr) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
US4314994A (en) * 1979-07-27 1982-02-09 Pierre Fabre S.A. Process for obtaining a plasminogen activator
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
GR79202B (fr) * 1982-05-05 1984-10-22 Genentech Inc
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
NL191755C (nl) * 1982-10-29 1996-07-02 Mitsui Toatsu Chemicals Plasminogeenactivator en trombolytisch middel.
EP0112122B1 (fr) * 1982-12-14 1991-08-28 South African Inventions Development Corporation Activateur de plasminogène
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
DE59009964D1 (de) * 1989-09-13 1996-01-25 Rieter Ag Maschf Verfahren zum Starten eines Arbeitsablaufs eines Bedienungsautomaten an einer Textilmaschine

Also Published As

Publication number Publication date
IL78937A (en) 1990-11-29
DK246886A (da) 1986-11-29
LU86445A1 (fr) 1986-12-05
SE8602404L (sv) 1986-11-29
ES555352A0 (es) 1987-07-01
FI85334C (fi) 1992-04-10
FI862226L (fi) 1986-11-29
IT1191925B (it) 1988-03-31
AU5796586A (en) 1986-12-04
PT82647B (pt) 1989-01-30
NO171344C (no) 1993-03-03
DK163174B (da) 1992-02-03
NZ216306A (en) 1989-10-27
FI85334B (fi) 1991-12-31
GB2176703A (en) 1987-01-07
GB2176703B (en) 1988-12-07
AU569429B2 (en) 1988-01-28
PT82647A (en) 1986-06-01
ATA141186A (de) 1990-06-15
IT8648064A0 (it) 1986-05-27
SE8602404D0 (sv) 1986-05-27
NL8601354A (nl) 1986-12-16
HUT42330A (en) 1987-07-28
DE3617753C2 (fr) 1988-06-30
DE3617753A1 (de) 1986-12-04
FR2593393B1 (fr) 1989-06-02
HU200695B (en) 1990-08-28
CA1297008C (fr) 1992-03-10
ES8706443A1 (es) 1987-07-01
DK163174C (da) 1992-06-22
GR861365B (en) 1986-09-29
FR2593393A1 (fr) 1987-07-31
GB8612781D0 (en) 1986-07-02
CH664495A5 (de) 1988-03-15
US5112609A (en) 1992-05-12
DK246886D0 (da) 1986-05-27
AT391812B (de) 1990-12-10
SE462893B (sv) 1990-09-17
IL78937A0 (en) 1986-09-30
NO862095L (no) 1986-12-01
FI862226A0 (fi) 1986-05-27
NO171344B (no) 1992-11-23

Similar Documents

Publication Publication Date Title
BE904831A (fr) Composition d'activateur tissulaire du plasminogene.
US4530787B1 (fr)
PT788509E (pt) Derivados peptidicos terapeuticos
ATE123949T1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
BE904830A (fr) Nouvelle composition d'activateur tissulaire du plasminogene.
ES2125718T3 (es) Purificacion de corriente de subproducto en la preparacion de poliesteres a base de 1,3-propanodiol.
DE3770915D1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
LV12000A (lv) Olbaltumviela ar uratoksidazes aktivitati un tas iegusana
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
DK1897552T3 (da) Polymer-konjugeret glycosyleret neublastin
ATE24917T1 (de) Peptide-derivate, deren herstellung und verwendung als elastasehemmende mittel.
KR910016767A (ko) 신규한 펩티드
DK0639202T3 (da) Stabil polypeptidsammensætning
AU2851389A (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
KR870010186A (ko) 가수분해효소 활성 축진제
ES2081797T3 (es) Aminoacidos y derivados peptidicos de 1,4-bis((aminoalquil e hidroxiaminoalquil)amino)-5,8-dihidroxiantraquinonas.
KR900001853A (ko) 변형된 인간 psti
SE8500093L (sv) Urokinasderivat
KR920018076A (ko) 신규 폴리펩티드
EA200001252A1 (ru) КОМПОЗИЦИЯ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА-β-1A(IFN-β-1A) ЧЕЛОВЕКА
ATE93731T1 (de) Protein enthaltende waesserige loesungen.
DE69000621D1 (de) Pentamidinloesungen.
PT84011A (fr) Procede de preparation de nouveaux analogues de composes polypeptidiques hypocalcemiants epargnant de calcium de l:organisme
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
KR970006314A (ko) 항균성 및 항진균성 활성을 갖는 폴리펩타이드

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19950531